Moderated by  Mara Aspinall, Health Catalysts  Panelists: Stacie Mallen, Vice President of Human Resources at Ulthera, Inc.; Brady Young, VP of HR for TGen, Adrienne Scheck, PhD, Associate Professor of Neurobiology at Barrow Neurological Institute; Tom Longstreth, Ventana Medical Systems, Inc., a member of the Roche Group

Glen Weiss, MD, MBA
Director of Clinical Research & Medical Oncologist
Western Regional Medical Center
Cancer Treatment Centers of America

The clinical research and trials program at Cancer Treatment Centers of America in Goodyear, Arizona has exponentially grown under the leadership of Dr. Glen Weiss.  Join us to learn more about groundbreaking new trials taking place here in our state - trials utilizing chemotherapy and immunotherapy together to harness the body's own immune system. Also, hear about CTCA’s vision for the future of cancer care.

Learn more about Arizona's Bioindustry. With over $19 Billion invested over the last two decades, the people of Arizona have come together to create one of the fastest growing bioscience sectors in the United States.

The AZBio Pioneer Award for Lifetime Achievement is the highest honor awarded by Arizona’s bioscience community and is extended to an Arizonan whose body of work has made life better for people at home and around the world. In 2019, we honor The Honorable Jane Dee Hull for the lasting impact her leadership has made on our bioscience industry and the State of Arizona. Looking back over close to six decades, there are many words that describe this incredible woman:  wife, mother, grandmother, teacher, legislator, first woman elected Speaker of the Arizona House of  Representatives, Arizona Secretary of State, 20th Governor of the State of Arizona beginning in 1997,  first woman elected Governor of Arizona in 1998, and public delegate from the United States to the United Nations General Assembly  in 2003.

https://www.azbio.org/the-honorable-jane-dee-hull-will-be-honored-with-the-azbio-pioneer-award-for-lifetime-achievement-at-the-2019-azbio-awards

Pain is real. If it is your pain, relief can be life changing. Regenesis Biomedical discovered an underutilized therapy and developed a unique platform that is delivering a solution to help patients manage their pain with a safe, easy to use, non-drug medical device.
Regenesis offers the Provant® Therapy System, an FDA-cleared medical device that is a safe, prescriptive non-drug alternative to opioids.  Regenesis’ customers include health care facilities and providers that serve patients treated in hospitals, rehabilitation centers, outpatient clinics, and by patients self-treating at home.

https://www.azbio.org/regenesis-biomedical-inc-named-arizona-bioscience-company-of-the-year

You probably know someone who is waiting for a cure. Most of us do.  It can take over 15 years and a billion dollars or more to bring a new life-saving or life-changing treatment to the people who are waiting for it,.  Throughout her career, Dr. Brumfield has worked to bring new, safe, and effective treatments to market for patients who are waiting.

https://www.azbio.org/martha-a-brumfield-phd-named-arizona-bioscience-leader-of-the-year

§  Mara Aspinall, Managing Director of BlueStone Venture Partners, shares insights on the vital role of research in the development and delivery of life changing and life saving innovations at the 2019 AZBio Awards

Laurence Hurley, PhD, is the Howard Schaeffer Chair in Pharmaceutical Sciences at the University of Arizona College of Pharmacy and director of the UA BIO5 College of Pharmacy Drug Discovery and Development Program. He also is a research member of the UA Cancer Center, among other roles. He is the leading authority on the identification of small molecule therapeutic agents that target DNA quadruplexes, which are unique four-stranded DNA structures that control gene expression.

More than 25 million Americans have asthma. This includes 7.7 percent of adults and 8.4 percent of children according to 2018 data from the U.S. Centers for Disease Control and Prevention. Dr. Kraft is an internationally renowned physician-scientist who specializes in translational asthma research. She focuses her work on precision medicine therapies to treat severe asthma. Her research has been funded by the National Institutes of Health (NIH) and the American Lung Association for nearly 25 years. As a principal investigator, she currently is in the third year of a 5-year, $7.02 million grant from the National Institute of Allergy and Infectious Diseases, an NIH unit, to study “Dysfunction of Innate Immunity in Asthma,” and in the first year of a 6-year, $2.42 million grant from the National Heart, Lung, and Blood Institute, another NIH unit, for participation in the PrecISE Network, a national research network that evaluates precision medicine approaches for the treatment of severe asthma. She also is principal investigator on an Arizona Biomedical Research Commission grant and co-principal investigator with Lynn Gerald, PhD, MSPH, as the UA is a site for the American Lung Association Clinical Research Centers to evaluate new treatments for asthma and chronic obstructive pulmonary disease (COPD).
https://www.azbio.org/monica-kraft-md-of-the-university-of-arizona-named-arizona-bioscience-researcher-for-the-year

Learning opportunities are all around us. Many of these opportunities are thanks to dedicated educators who work to make them engaging, enlightening and memorable. They help us understand the world we live in today and provide tools we can use to shape our tomorrows. Dr. Marti Lindsey is a great example of an educator who is making a difference here in Arizona and across the Southwest region.

https://www.azbio.org/marti-lindsey-phd-of-the-university-of-arizona-to-be-honored-as-the-michael-a-cusanovich-arizona-bioscience-educator-of-the-year